Aster DM Healthcare Limited

NSE ASTERDM.NS

Aster DM Healthcare Limited Price to Sales Ratio (P/S) on January 14, 2025: 6.45

Aster DM Healthcare Limited Price to Sales Ratio (P/S) is 6.45 on January 14, 2025, a 298.46% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Aster DM Healthcare Limited 52-week high Price to Sales Ratio (P/S) is 551.32 on December 20, 2024, which is 8,441.40% above the current Price to Sales Ratio (P/S).
Aster DM Healthcare Limited 52-week low Price to Sales Ratio (P/S) is 1.62 on January 15, 2024, which is -74.90% below the current Price to Sales Ratio (P/S).
Aster DM Healthcare Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 6.94.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NSE: ASTERDM.NS

Aster DM Healthcare Limited

CEO	Ms. Alisha Moopen
IPO Date	Feb. 26, 2018
Location	United Arab Emirates
Headquarters	Tower D - Aspect Tower
Employees	14,016
Sector	Health Care
Industries Hospitals & Clinics Drugstores & Retail Pharmacies Pharmaceuticals Specialty Retail

Description

Aster DM Healthcare Limited operates as a healthcare company in India and internationally. The company operates through Hospitals, Clinics, Retail Pharmacies, and Other segments. It provides primary, secondary, tertiary, and quaternary healthcare services through 29 hospitals, 120 clinics, 371 retail pharmacies, 114 labs, and patient experience centers under the Aster, Medcare, and Access brands. In addition, it offers healthcare retailing, diagnostic laboratories, digital health, and medical education services. The company was founded in 1987 and is headquartered in Dubai, the United Arab Emirates.

Key trends

Past 5 years